Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-17T01:56:08.196Z Has data issue: false hasContentIssue false

Minaprine in Depression

A Controlled Trial with Amitriptyline

Published online by Cambridge University Press:  02 January 2018

David Wheatley*
Affiliation:
Psychopharmacology Research Group, 5 Warblers Green, Cobham, Surrey KT11 2NY
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Minaprine (200 mg daily, either once or divided b.d.) was compared with amitriptyline (25–50 mg t.d.s.) over six weeks in 144 patients with major depression. Significant reductions in HRSD scores at the end of six weeks' treatment were recorded with both dose regimes of minaprine and with amitriptyline, with no significant differences between them. There was a significantly greater incidence of drowsiness and dry mouth with amitriptyline than with minaprine.

Information

Type
Brief Reports
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.